Bessemer Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 5,252 shares of REGN stock, worth $3.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,252
Previous 5,093 3.12%
Holding current value
$3.94 Million
Previous $5.35 Million 3.12%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1024.09 - $1201.76 $162,830 - $191,079
159 Added 3.12%
5,252 $5.52 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $15,897 - $19,281
18 Added 0.35%
5,093 $5.35 Million
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $2.37 Million - $2.61 Million
2,624 Added 107.06%
5,075 $4.89 Million
Q4 2023

Feb 09, 2024
SELL
$775.18 - $881.7 $250,383 - $284,789
-323 Reduced 11.64%
2,451 $2.15 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $45,009 - $54,884
-65 Reduced 2.29%
2,774 $2.28 Million
Q2 2023

Aug 10, 2023
BUY
$700.03 - $830.35 $205,108 - $243,292
293 Added 11.51%
2,839 $2.04 Million
Q1 2023

May 10, 2023
SELL
$680.49 - $826.97 $285,805 - $347,327
-420 Reduced 14.16%
2,546 $2.09 Million
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $24,706 - $26,823
35 Added 1.19%
2,966 $2.14 Million
Q3 2022

Nov 09, 2022
BUY
$573.97 - $724.32 $145,788 - $183,977
254 Added 9.49%
2,931 $2.02 Million
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $22,482 - $30,292
41 Added 1.56%
2,677 $1.58 Million
Q1 2022

May 12, 2022
BUY
$595.12 - $698.43 $258,877 - $303,817
435 Added 19.76%
2,636 $1.84 Million
Q4 2021

Jan 27, 2022
BUY
$543.48 - $670.97 $382,609 - $472,362
704 Added 47.03%
2,201 $1.39 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $25,831 - $30,643
45 Added 3.1%
1,497 $905,000
Q2 2021

Aug 06, 2021
BUY
$472.8 - $558.54 $25,531 - $30,161
54 Added 3.86%
1,452 $811,000
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $102,301 - $125,537
229 Added 19.59%
1,398 $661,000
Q4 2020

Feb 09, 2021
SELL
$478.3 - $607.98 $51.1 Million - $64.9 Million
-106,817 Reduced 98.92%
1,169 $565,000
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $9.45 Million - $11.4 Million
17,341 Added 19.13%
107,986 $60.4 Million
Q2 2020

Aug 05, 2020
BUY
$493.32 - $643.92 $1.26 Million - $1.65 Million
2,558 Added 2.9%
90,645 $56.5 Million
Q1 2020

Apr 30, 2020
BUY
$336.18 - $494.43 $45,384 - $66,748
135 Added 0.15%
88,087 $43 Million
Q4 2019

Feb 04, 2020
SELL
$274.13 - $376.51 $7.4 Million - $10.2 Million
-26,983 Reduced 23.48%
87,952 $33 Million
Q3 2019

Nov 07, 2019
SELL
$273.46 - $318.39 $2.32 Million - $2.71 Million
-8,497 Reduced 6.88%
114,935 $31.9 Million
Q2 2019

Jul 19, 2019
BUY
$299.6 - $414.82 $36.8 Million - $50.9 Million
122,811 Added 19776.33%
123,432 $38.6 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $46,882 - $55,385
126 Added 25.45%
621 $255,000
Q4 2018

Feb 12, 2019
BUY
$335.82 - $403.04 $31,567 - $37,885
94 Added 23.44%
495 $184,000
Q3 2018

Nov 06, 2018
SELL
$351.14 - $408.51 $2,106 - $2,451
-6 Reduced 1.47%
401 $163,000
Q2 2018

Jul 25, 2018
SELL
$284.6 - $344.99 $134,900 - $163,525
-474 Reduced 53.8%
407 $140,000
Q1 2018

May 10, 2018
BUY
$315.82 - $393.78 $160,436 - $200,040
508 Added 136.19%
881 $304,000
Q4 2017

Jan 30, 2018
SELL
$358.63 - $469.95 $104,002 - $136,285
-290 Reduced 43.74%
373 $141,000
Q3 2017

Nov 03, 2017
BUY
$431.38 - $504.0 $286,004 - $334,152
663
663 $297,000

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email